In this review:
This publication provides summaries of key clinically relevant multiple myeloma data presented at the 59th ASH Annual Meeting and Exposition, 9–12 December 2017 in Atlanta, Georgia, USA. The Chair (Associate Professor Peter Mollee) and clinicians involved in the Australian and New Zealand Myeloma Ambassador Program (ANZMAP) selected the presentations and when germane provided a brief commentary.
Download PDF